![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GE HealthCare Technologies Inc | NASDAQ:GEHC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 80.19 | 78.51 | 81.90 | 75 | 09:29:03 |
By Will Feuer
GE Healthcare Technologies Inc. issued preliminary results for the fourth quarter and forecasted continued organic revenue growth in the year ahead.
Supply-chain challenges are easing and demand for the company's products and services is improving, Chief Executive Peter Arduini said. Inflation remains a factor, he said.
The company, which completed its spinoff from General Electric Co. last week, said it expects 2023 organic revenue to grow by 5% to 7% from 2022 levels. In 2022, organic revenue grew by about 7%, the company said.
For the fourth quarter, the company said revenue was about $4.9 billion, growth of about 12% on an organic basis, which strips out currency fluctuations as well as recent acquisitions and divestitures. For 2022, the company expects to report adjusted earnings before interest and taxes above outlook.
The company said 2022 free-cash flow is expected to come in toward the low end of the range that the company provided at an investor day presentation last month on both a GE and GEHC basis.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
January 10, 2023 07:07 ET (12:07 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year GE HealthCare Technologies Chart |
1 Month GE HealthCare Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions